Vista Pharmaceuticals Ltd.
BSE: 524711 | Sector: Health care |
NSE: N.A. | ISIN Code: INE427C01021 |
BSE 00:00 | 23 May | 7.09 |
0.28 (4.11%) |
OPEN
6.95 |
HIGH
7.13 |
LOW
6.59 |
NSE 05:30 | 01 Jan | Vista Pharmaceuticals Ltd |
OPEN | 6.95 |
PREVIOUS CLOSE | 6.81 |
VOLUME | 13141 |
52-Week high | 15.97 |
52-Week low | 6.51 |
P/E | |
Mkt Cap.(Rs cr) | 26 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Vista Pharmaceuticals Ltd. (VISTAPHARMA) - Latest News & Headlines
-
Vista Pharmaceuticals Ltd Board Meeting Intimation for Approval Of Financial Results For The Quarter And Year Ended 31.03.2022
23/05/2022 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2022
21/04/2022 | bse
-
Vista Pharmaceuticals Ltd Closure of Trading Window
31/03/2022 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Financial Results For The Quarter Ended 3Lst December2021 - Regulation 33 (3) (A)
14/02/2022 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Board Meeting Outcome for Approval Of Un-Audited Financial Results For The Quarter Ended 31St Decemb
14/02/2022 | bse |
Downlaod PDF
-
Aditya Birla Fashion to sell minority stake to private equity firms
2.19 am | 24 May 2022 | Business Standard
On Monday, the stock closed flat at Rs 273 a share, thus, giving a total market valuation of Rs 25,618 crore to the company
-
Cement prices may fall after excise duty cut on fuel, helping infra sector
7.29 pm | 23 May 2022 | Business Standard
Shree Cement says will take a cut of Rs 5 per bag and other companies are expected to decide soon.
-
Tata Steel, SAIL: Should you Buy or Sell them? Here's what charts suggest
12.23 pm | 23 May 2022 | Business Standard
Charts of steel stocks signal further downside, indicating a fall up to 20 per cent in select shares; cement counters indicate a wait-and-watch approa...
-
Tata Steel, SAIL: Should you Buy or Sell them? Here's what charts suggest
12.23 pm | 23 May 2022 | Business Standard
Charts of steel stocks signal further downside, indicating a fall up to 20 per cent in select shares; cement counters indicate a wait-and-watch approa...
-
Ruchi Soya acquires Patanjali Ayurved's food business for Rs 690 crore
1.32 am | 19 May 2022 | Business Standard
To pay 1% of turnover of products as annual royalty under transfer agreement
Quick Links for Vista Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices